UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000023070
Receipt No. R000026592
Official scientific title of the study Evaluation of efficacy and safety profiles of tribulus terristrus in males with partial androgen deficiency and erectile dysfunction and lower urinary tract symptoms in a placebo controlled study
Date of disclosure of the study information 2016/07/08
Last modified on 2018/04/12 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of efficacy and safety profiles of tribulus terristrus in males with partial androgen deficiency and erectile dysfunction and lower urinary tract symptoms in a placebo controlled study
Title of the study (Brief title) Safety and efficacy of tribulus terristrus in PADAM patients with erectile dysfunction and LUTS in a placebo controlled study
Region
Africa

Condition
Condition partial androgen deficiency with erectile dysfunction and low libido
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 potential roles of mesterolone and tribulus terristrus in PADAM patients
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Not yet available as the study is pre-intiating
Key secondary outcomes Not yet available as the study is pre-intiating

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is considered as adjustment factor in dynamic allocation.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 one group of the PADAM patients will recieve placebo 3 times daily for 3 months with follow up of PSA / liver enzymes/ testosterone/ international prostate symptoms score (IPSS)/ validated Arabic version of international index of erectile function (IIEF)
Interventions/Control_2 one group of the PADAM patients will recieve tribulus terristrus 3 times daily for 3 months with follow up of PSA / liver enzymes/ testosterone/ international prostate symptoms score (IPSS)/ validated Arabic version ofinternational index of erectile function (IIEF)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
72 years-old >=
Gender Male
Key inclusion criteria PADAM patients with erectile dysfunction and
lower urinary tract symptoms
Key exclusion criteria 1)PADAM patients without erectile dysfunction and low libido
2)PADAM patients with major systemic illness, smoking, drug addict, alcohol abuse
Target sample size 70

Research contact person
Name of lead principal investigator sameh fayek
Organization cairo university
Division name Andrology & STDs
Address Al-Saray Street, El Manial Cairo-11956-Egypt
TEL 01227109309
Email samehfayek@hotmail.com

Public contact
Name of contact person Sameh Fayek
Organization Cairo University
Division name Andrology department
Address Al-Saray Street, El Manial Cairo-11956-Egypt
TEL 01227109309
Homepage URL http://scholar.cu.edu.eg/sfayek/
Email samehfayek@kasralainy.edu.cu.eg

Sponsor
Institute cairo university
Institute
Department

Funding Source
Organization cairo university
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 08 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2017 Year 03 Month 18 Day
Anticipated trial start date
2017 Year 06 Month 20 Day
Last follow-up date
2018 Year 03 Month 29 Day
Date of closure to data entry
2018 Year 03 Month 29 Day
Date trial data considered complete
2018 Year 03 Month 29 Day
Date analysis concluded
2018 Year 04 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 07 Month 08 Day
Last modified on
2018 Year 04 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026592